ClinicalTrials.Veeva

Menu

Tongzhou Cohort Study

Capital Medical University logo

Capital Medical University

Status

Active, not recruiting

Conditions

Hypertension
Obesity

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05156580
2021-P2-163-01

Details and patient eligibility

About

Long-term Impact of Overweight/Obesity and Hypertension on Cardiovascular Risk in Middle-aged and Elderly Adults

Full description

Overweight and obesity are major risk factors associated with the development of hypertension, poor blood pressure control, and adverse cardiovascular outcomes. However, evidence regarding the long-term impact of overweight/obesity and hypertension on cardiovascular risk in middle-aged and elderly populations remains limited. Therefore, the present study aims to evaluate the long-term effects of overweight/obesity and hypertension on cardiovascular risk in middle-aged and elderly adults.Additionally, a subgroup analysis will be conducted in participants with sarcopenia to assess the influence of blood pressure on prognosis, exploring potential interactions between muscle loss, hypertension, and cardiovascular outcomes.

Enrollment

31,080 patients

Sex

All

Ages

45+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Ages of ≥ 45 years
  • Participants from routine health examinations at Tongzhou Community Health Service Center
  • Availability for follow-up until 2026
  • No major barriers to provide written consent

Exclusion criteria

  • NA

Trial design

31,080 participants in 6 patient groups

Obese hypertensive group
Description:
Patients who were diagnosed with obesity (body mass index (BMI)≥28kg/m2) and hypertension (systolic blood pressure (SBP)/diastolic blood pressure (DBP) ≥ 140/90 mmHg).
Treatment:
Other: No intervention
Overweight hypertensive group
Description:
Overweight patients (24 kg/m2≤BMI≤28 kg/m2) diagnosed with hypertension (SBP/DBP≥140/90 mmHg).
Treatment:
Other: No intervention
Lean hypertensive group
Description:
Lean patients (BMI ≤ 24 kg/m2) diagnosed with hypertension (SBP/DBP ≥ 140/90 mmHg).
Treatment:
Other: No intervention
Lean normotensive
Description:
Lean patients (BMI ≤ 24 kg/m2) diagnosed with normotensive (SBP/DBP \< 140/90 mmHg).
Treatment:
Other: No intervention
Overweight normotensive
Description:
Overweight patients (24 kg/m2≤BMI≤28 kg/m2) diagnosed with normotensive (SBP/DBP\<140/90 mmHg)
Treatment:
Other: No intervention
Obese normotensive
Description:
Patients who were diagnosed with obesity (BMI≥28kg/m2) and normotensive (SBP/DBP\<140/90 mmHg).
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Rongchong Huang, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems